MCKEE KELLY T. JR. (Chief Medical Officer) purchased 46.4% of their position (1.11K shares) of GEOVAX LABS, INC. on the open market
Open‑market purchase worth $741.69 — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/8/2025ACC: 0001437749-25-025690
Officer· Chief Medical Officer
Since Jan 2022
+1.11K
Net shares
Net buyer
$741.69
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.11K
Price / share
$0.67
Trade value
$741.69
% of position
46.4%
8/7/2025
2.39K→3.49K
Total
Net shares
+1.11K
Net value
$741.69
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2025 | P · Purchase | +1.11K | $0.67 | $741.69 | 46.4% | 2.39K | 3.49K |
| Total | +1.11K | $741.69 | ||||||
Derivative Transactions0
No derivative transactions reported